SHOCKING: 17 - What They Never Told You

10 Biggest Price Target Changes For Thursday

Piper Sandler cut the price target on Wingstop Inc. (NASDAQ: WING) from $195 to $102. Wingstop shares fell 0.7% to trade at $111.44 on Thursday.

Benzinga · Mar 24, 2022

Piper Comments On Increased Interest To Invest In Arcturus, 'Incrementally Positive' On Argenx

Piper Sandler noted that Arcturus Therapeutics Holdings Inc's (NASDAQ: ARCT) recently filed 10-K mentions funding of $25 million from a "pharmaceutical company" to run a clinical trial for LUNAR-COV19 vaccine candidate as a booster. 

Benzinga · Mar 22, 2022

Piper Sandler Increases Catalyst Pharma's Price Target Slightly After Q4 Earnings

Piper Sandler raised the price target marginally on Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) to $8.75 from $8.00, with an Overweight rating unchanged.  Catalyst expects FY22 revenue of $195 million - $205 million, driven by transitioning ~125 patients previously on Ruzurgi onto Firdapse, analyst Joseph Catanzaro writes in a research note.  Wall Street's estimate for sales…

Benzinga · Mar 17, 2022

Piper Sandler Remains Cautious On Tesla Despite Noting Its Strength

Piper Sandler analyst Alexander Potter admitted that the current weekly China Passenger Car Association February sales and production exhibited continued strength for Tesla Inc's (NASDAQ:TSLA) Shanghai factory.  Tesla sold 56,515 China-made vehicles in February, including 33,315 for export. Potter also noticed a "general uptick in inbound calls" from investors regarding Tesla's exposure to geopolitical risks and commodity price…

Benzinga · Mar 10, 2022

Why Palantir Shares Are Ripping Higher

Palantir Technologies Inc (NYSE: PLTR) is surging Wednesday after Piper Sandler analyst Weston Twigg initiated coverage on the stock with an Overweight rating and a $15 price target.

Benzinga · Mar 9, 2022

Analysts Continue To See Sharp Upside In Bumble Post Q4

Analysts continue to see sharp upside in Bumble Inc (NASDAQ:BMBL) despite cutting their price targets post Q4 results. BMO Capital analyst Daniel Salmon upgraded to Outperform from Market Perform with an unchanged price target of $48 (103% upside). Online dating is poised to outperform the internet sector. Cowen analyst John Blackledge raised the price target to $38…

Benzinga · Mar 9, 2022

Why This Data Analytics Company's 'High Growth' Will Likely Continue

Palantir Technologies Inc. (NYSE: PLTR), while being controversial, has set its sights on achievable growth targets, according to an analyst at Piper Sandler.

Benzinga · Mar 9, 2022

Piper Sandler Slashes Facebook Parent Meta's Price Target By 20%; Reiterates Overweight

Piper Sandler cut its price target on the Meta Platforms Inc (NASDAQ: FB), noting that its advertising headwinds are likely to continue for several months. Analyst Thomas Champion lowered his price target to $240 from $301, implying a 28% upside. 

Benzinga · Mar 8, 2022

Evolent Health 'Notification Award' Removes $82M Overhang, Notes Piper Sandler

In an SEC filing, Cook County named Evolent Health Inc (NYSE:EVH) the sole third-party administrator for CountyCare Health Plan from fiscal 2023 through fiscal 2025. Piper Sandler analyst Jessica Tassan notes that the award extends a contract Evolent has held since fiscal 2018 to provide administrative simplification services to support CountyCare's 425,000 Medicaid…

Benzinga · Mar 7, 2022

Analysts Move To Sidelines On Vicarious Surgical After Regulatory Update

Piper Sandler has downgraded Vicarious Surgical Inc (NASDAQ:RBOT) to Neutral from Overweight with a price target of $7, down from $16, below expected Q4 results.  A majority of the earnings call focused on the Company's regulatory update. Vicarious announced its plans to pursue a De Novo FDA pathway, including a pre-market study, for its…

Benzinga · Mar 4, 2022